Brief: Bruker Advances Functional Proteomics With Novel Timsultra Aip And Timsomni Workflows For Drug Discovery & Development And Disease Biology Research
BRIEF-Bruker Advances Functional Proteomics With Novel Timsultra Aip And Timsomni Workflows For Drug Discovery & Development And Disease Biology Research Sept 28 (Reuters) - Bruker Corporation BRKR.O:
BRUKER ADVANCES FUNCTIONAL PROTEOMICS WITH NOVEL TIMSULTRA AIP AND TIMSOMNI WORKFLOWS FOR DRUG DISCOVERY & DEVELOPMENT AND DISEASE BIOLOGY RESEARCH
Source text: ID:nBw8rhJ8pa
Further company coverage: BRKR.O
((Reuters.Briefs@thomsonreuters.com;;))